It is the question almost every patient asks once the scale starts moving: am I losing fat, or am I losing muscle? It is a fair question, and it deserves a real answer rather than reassurance. Weight loss of any kind — from a calorie-restricted diet, from bariatric surgery, or from a GLP-1 medication like semaglutide or tirzepatide — reduces both fat mass and lean mass. What separates a good outcome from a disappointing one is not whether you lose any lean tissue, but how much, how fast, and what you do alongside the medication to protect the muscle you have.

At Contour Medical Clinic in Tarzana, muscle preservation is treated as part of the weight loss plan rather than an afterthought. This guide explains what the research actually shows about lean mass and GLP-1 therapy, why muscle matters well beyond appearance, and the specific, evidence-based levers — protein, resistance training, dose pacing, and measurement — that help you finish a weight loss program stronger than you started.

What "lean mass" actually means

Lean mass, sometimes called fat-free mass or lean soft tissue, is everything in your body that is not fat: skeletal muscle, organs, connective tissue, and the water held inside those tissues. When a body composition report says you lost lean mass, that number is not purely muscle. It includes glycogen and its associated water, reductions in organ and gut tissue that accompany a smaller body, and normal fluid shifts.

This distinction matters because it explains why early lean mass readings can look alarming. In the first weeks of a lower-calorie intake, glycogen stores drop and each gram of stored glycogen releases roughly three to four grams of water with it. On a scan, that shows up in the lean column. It is not lost muscle, and it largely stabilizes once intake and body weight settle.

What the research shows about GLP-1 medications and lean mass

The most frequently cited data comes from body composition sub-analyses of the major trials.

In an exploratory analysis of the STEP 1 trial — 140 participants who received DXA scans, randomized to once-weekly semaglutide 2.4 mg or placebo alongside lifestyle intervention over 68 weeks — participants on semaglutide saw total fat mass fall by 19.3% and total lean body mass fall by 9.7% from baseline. Critically, lean mass as a proportion of total body mass increased by about 3 percentage points. In other words, participants ended the trial with a body that was proportionally leaner, even though the absolute amount of lean tissue was lower.

Across the broader literature on GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists, lean soft tissue has generally accounted for somewhere in the range of a quarter to roughly 40% of total weight lost, depending on the trial, the population, and the measurement method. That proportion is broadly comparable to what is observed with diet-induced weight loss. The important nuance is one of arithmetic: because these medications produce substantially more total weight loss than lifestyle change alone, a similar percentage translates into a larger absolute amount of lean tissue lost.

Network meta-analyses comparing agents have found that the most potent options for total weight and fat reduction — tirzepatide at higher doses and semaglutide 2.4 mg — also tend to rank among the less lean-mass-sparing. Recent preclinical and clinical work published in 2026 has pushed back on the idea that GLP-1 medications are uniquely harmful to muscle, concluding that the tissue loss observed appears proportionate to the magnitude of weight loss rather than a distinct drug effect on muscle. The practical takeaway is consistent across both interpretations: the driver is how much weight you lose and how you support your body while losing it.

One caveat worth naming. Different trials use different measurement tools and different definitions, which is part of why published figures vary so widely. Numbers from one study should not be read as a prediction of what any individual will experience.

Why muscle is worth protecting

Muscle is not simply an aesthetic concern. It does real metabolic and functional work.

• Metabolic rate. Skeletal muscle is metabolically active tissue. Losing a meaningful amount of it lowers resting energy expenditure, which makes maintaining weight loss harder after you reach your goal.
• Glucose handling. Muscle is the largest site of glucose disposal in the body. More muscle generally supports better insulin sensitivity.
• Strength and independence. Grip strength, gait speed, and the ability to rise from a chair are among the best predictors of long-term functional health, particularly past midlife.
• Bone and joint support. Loading muscle through resistance work also loads bone, which matters during periods of weight loss when bone mineral density can decline.
• How you look at the finish line. Two people can reach the same weight with very different physiques. The one who held onto lean tissue looks and feels firmer.

Five ways to protect lean mass on a GLP-1 program

1. Prioritize protein — and front-load it

Adequate protein is the single most established nutritional lever for preserving lean tissue during weight loss. Research and clinical guidance in this area commonly work within a range of roughly 1.2 to 1.6 grams of protein per kilogram of body weight per day during active weight loss, with intervention studies in overweight and sarcopenic-obese populations testing intakes spanning approximately 1.0 to 1.8 g/kg/day. Your own target should be set by your clinician, and it may need to be adjusted — protein recommendations differ for people with kidney disease, and appetite suppression makes hitting any target harder than it sounds.

Distribution matters as much as the total. Spreading protein across meals stimulates muscle protein synthesis more effectively than concentrating it in one evening meal. This is especially relevant on GLP-1 therapy, because delayed gastric emptying means many patients feel fullest later in the day. Front-loading protein at breakfast and lunch, when appetite tends to be more cooperative, is a practical workaround. Liquid and semi-liquid protein sources are often better tolerated than dense solids on injection-week days.

2. Lift something heavy, two to three times a week

Resistance training is the strongest signal you can send your body to keep the muscle it has. In the sarcopenic obesity literature, resistance training performed two to three times per week for roughly 20 to 60 minutes per session is associated with reduced body fat percentage alongside improvements in muscle mass, strength, and gait speed. Combining resistance training with higher protein intake consistently outperforms either strategy alone.

You do not need an elaborate program. Compound movements that load multiple joints — squats, hinges, presses, rows, carries — cover the majority of the benefit. What matters is progression: adding weight, reps, or sets over time so the stimulus keeps pace with your improving capacity. Cardiovascular exercise is valuable for heart health and appetite regulation, but it is not a substitute for resistance work when the goal is holding lean mass.

3. Do not chase the fastest possible weight loss

Faster weight loss generally means a larger share of the loss comes from lean tissue. The goal of dose titration is not to reach the maximum tolerated dose as quickly as possible; it is to find the dose that produces steady fat loss while you eat enough protein, train consistently, and feel well. If your body composition data shows fat coming down and lean mass holding, there is often no clinical reason to escalate further. That judgment belongs in a conversation with your prescribing clinician, not in a comparison with someone else's timeline.

4. Measure body composition, not just body weight

The bathroom scale cannot tell you what kind of weight you are losing, which makes it a poor instrument for the question that matters most. Body composition analysis separates fat mass from skeletal muscle mass and tracks each over time.

A note on methods: DXA is generally regarded as the reference standard for body composition, while multi-frequency bioelectrical impedance — the technology behind InBody devices used in many clinical settings — is fast, non-invasive, and well suited to repeated measurement, though it tends to read fat-free mass somewhat higher and fat mass somewhat lower than DXA. The practical implication is not that one is right and the other wrong; it is that you should compare like with like. Use the same device, at a similar time of day, under similar hydration and food conditions, and read the trend rather than any single number. A deeper explanation of what each metric means is available in our guide to body composition analysis in Tarzana.

5. Look for the reversible causes hiding underneath

Sometimes stubborn lean mass loss is not about the medication at all. Low testosterone, thyroid dysfunction, inadequate overall calorie intake, poor sleep, low vitamin D, and iron deficiency can all undermine your ability to build or hold muscle. Comprehensive lab testing can identify these before they quietly derail months of effort.

For some patients, addressing an underlying hormonal issue changes the trajectory entirely. Our guides to TRT and the 2026 testosterone guidelines and to hormone optimization for men and women cover how that evaluation works. Any hormone therapy decision is individualized and requires appropriate lab confirmation and physician supervision.

What about medications or peptides marketed for muscle preservation?

This is a common question, and it deserves a careful answer. Several investigational compounds designed to preserve or increase lean mass during weight loss are currently in clinical trials. As of this writing, none is FDA-approved for the purpose of preventing muscle loss during GLP-1 therapy, and any product marketed to consumers with that specific promise is making a claim that outruns the regulatory evidence.

Peptide therapy is a legitimate and evolving area of medicine, but it is not a shortcut around protein and training, and it is not appropriate for everyone. If you are curious, our overview of peptide therapy — types, benefits, and safety lays out what is established and what is not. Any decision belongs in a supervised clinical conversation where your history, labs, and goals are on the table.

Where recovery fits in

Muscle is built between training sessions, not during them, which makes recovery a legitimate part of a body composition strategy rather than a luxury. Sleep is the highest-leverage recovery variable by a wide margin. Beyond that, consistent recovery habits help people stay in a training program long enough for it to work — and adherence, not optimization, is where most plans fail.

Members of Club Contour Studios often pair strength work with sessions in the Wellness Lounge, using the infrared sauna, cold plunge, or contrast therapy to manage post-training soreness and wind down. Hydration matters too, particularly when appetite suppression reduces fluid intake from food; some patients use IV hydration therapy or mobile IV therapy for that reason. These are supportive comforts that help you keep showing up, not muscle-building interventions in their own right.

Skin laxity is a related concern that often surfaces during significant weight loss. Non-invasive radiofrequency treatments in the Contour Lounge address skin tightening and contour, and are entirely separate from the metabolic work described here.

Frequently asked questions

Will I definitely lose muscle on semaglutide or tirzepatide?

Some lean tissue loss accompanies essentially all meaningful weight loss, whether it comes from medication, diet, or surgery. The amount varies considerably between individuals and is influenced by protein intake, resistance training, rate of loss, age, and baseline muscle mass. It is not a fixed outcome.

How much protein should I eat?

Ranges around 1.2 to 1.6 g/kg/day are commonly used during active weight loss, with research protocols spanning roughly 1.0 to 1.8 g/kg/day. Your specific target should be set by your clinician based on your body weight, kidney function, and overall health. Do not self-prescribe an aggressive intake without that conversation.

Can I build muscle while losing fat on a GLP-1?

Simultaneously gaining muscle while in a calorie deficit is possible for some people — most often those new to resistance training or returning after a long break — but it is not the typical outcome. For most patients on a GLP-1, a realistic and worthwhile goal is to preserve lean mass while fat mass falls.

How often should I get a body composition scan?

Frequently enough to see a trend and infrequently enough to avoid reacting to noise. Many programs re-measure every four to twelve weeks. Consistency of conditions matters more than frequency.

What happens to my muscle if I stop the medication?

Weight regain after discontinuation is well documented, and regained weight tends to be disproportionately fat rather than muscle. This is a strong argument for building durable protein and training habits during treatment rather than treating them as optional add-ons — and for discussing any plan to stop with your prescribing clinician rather than stopping abruptly on your own.

Is cardio bad for muscle preservation?

No. Cardiovascular exercise supports heart health, appetite regulation, and overall fitness. The point is that it does not replace resistance training when the specific goal is protecting lean mass. Both have a place.

The bottom line

GLP-1 medications are among the most effective tools available for treating obesity, and the lean mass question is not a reason to avoid them. It is a reason to use them inside a structured program. Eat enough protein and spread it across the day. Lift with progression two to three times a week. Let the dose serve the goal rather than the other way around. Measure body composition instead of just weight. And check for the underlying issues — hormonal, nutritional, or otherwise — that quietly make muscle harder to keep.

Done properly, the goal is not simply a smaller version of you. It is a stronger, more metabolically healthy one.

Talk with a clinician in Tarzana

If you are on a GLP-1 medication or considering one, and you want a plan that protects lean mass rather than ignoring it, Contour Medical Clinic offers physician-supervised medical weight loss in Tarzana that incorporates body composition tracking, lab work, and nutrition and training guidance alongside the prescription. We serve patients throughout the San Fernando Valley, including Encino, Woodland Hills, Sherman Oaks, and Reseda.

Request a medical weight loss consultation to discuss your goals, your current program, and what protecting your muscle would look like in practice.

This article is for general educational purposes and does not constitute medical advice, diagnosis, or treatment. Individual results vary. Medication decisions, dosing, and nutrition targets should be made with a qualified healthcare provider who knows your medical history.

Written by: Contour Medical Clinic Editorial Team